VOO is closing out the week with its options market planted firmly in bullish territory — and the shift from last week's defensive extreme has now become structural rather than a one-day flush.
The options signal is the story this week. The put/call ratio has collapsed to 0.68, the second-lowest reading of the past year, sitting nearly 2.7 standard deviations below its 20-day mean of 1.71. That mean itself — heavily weighted by the defensive prints from the prior two weeks, when the PCR hit a 52-week high of 2.00 — illustrates how complete the rotation has been. Two weeks ago, options traders were running maximum hedges against the S&P 500. Now they have stripped most of those protections off. The question from last week's note — whether Tuesday's bullish flush was genuine repositioning or a one-session anomaly — has a cleaner answer this week: the positioning has held and deepened, not reversed.
Price action supports the mood shift. VOO gained 2.3% on the week and 5.1% over the past month, closing at $690.01 — a level that, in context, represents a meaningful recovery from the volatility-driven lows earlier in the spring. The one-month gain has been consistent and relatively smooth, with no sharp intra-week reversals visible in the close-level data.
Short interest is barely worth a paragraph, and that itself is part of the story. SI is 0.41% of the float — negligible by any standard — and has nudged just 2.4% higher on the week. Borrow availability is effectively unlimited, with over 1.3 billion shares available to lend, far exceeding anything that could be classified as a squeeze setup. Cost to borrow is 0.40%, trivial for an instrument of this size and liquidity. The borrow market for VOO is about as loose as it gets for any US-listed security.
The institutional flow data offers a different kind of signal. JPMorgan added 15.3 million shares in Q1 2026, the largest single-quarter change among the top 15 disclosed holders. Vanguard Global Advisers added 33.5 million shares in the same period — though in the context of an internal Vanguard entity managing a Vanguard product, that reading carries different weight than a third-party institutional accumulation. CalPERS added a further 2.0 million shares. Envestnet added 4.2 million. The pattern across multiple large holders is consistent with ongoing systematic accumulation rather than tactical positioning.
What to watch next: whether the PCR continues consolidating at these low levels or starts rebuilding put demand — a resumption toward the 1.7 average would signal returning caution after what has been a clean, month-long de-hedging cycle.
See the live data behind this article on ORTEX.
Open VOO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.